Update on community-acquired pneumonia: Impact of antibiotic resistance on clinical outcomes

Current Opinion in Infectious Diseases

Volumn 15, Issue 2, 2002, Pages 163-167

  Metlay, Joshua P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIUM ISOLATE; CLINICAL OBSERVATION; CLINICAL TRIAL; COHORT ANALYSIS; HUMAN; MEDICAL LITERATURE; OUTCOMES RESEARCH; PNEUMONIA; PUBLICATION; RETROSPECTIVE STUDY; REVIEW; SAMPLE SIZE; STREPTOCOCCUS PNEUMONIAE;

EID: 0036212490     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200204000-00011     Document Type: Review

References (16)

1. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program
2. Macrolide resistance among invasive Streptococcus pneumoniae isolates
3. Practice guidelines for the management of community-acquired pneumonia in adults
4. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention
5. Management of community-acquired pneumonia in the era of pneumococcal resistance: A report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group
6. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997
7. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia
8. Streptococcus pneumoniae: Bacteremia in an era of penicillin resistance
9. A comparative clinical study of pneumonia by penicillin-resistant and sensitive Streptococcus pneumoniae in a community hospital
10. Pneumonia caused by penicillin-nonsusceptible Streptococcus pneumoniae: Clinical characteristics, prognostic factors, and outcomes
11. Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance
12. Antimicrobial treatment failures in patients with community-acquired pneumonia: Causes and prognostic implications
13. Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin
14. Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: A randomized study of amoxicillin-clavulanate and ceftriaxone
15. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States